The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Author Archives: pcbd-admin
Project CBD Newsletter: Synthetic Cannabinoids in Hemp Products, CBD and Melanoma, Cannabis Roots, Neuroprotection, Antimicrobial Research, and More
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: MDMA and Memory Impairment, Ibogaine Safety, Psychedelic Industry Ethics, CBD Liver Study, Prenatal Cannabis Exposure, Migraine Relief, and CBD for Autism
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Cannabis Use Linked to Greater Cognitive Performance in Seniors, CBD Research Round-Up, and Semi-Synthetic Cannabinoid Challenges
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Microdosing Psilocybin and Creativity, Non-Hallucinogenic Psychoplastogens, Neuroplasticity, Psychedelic Product Integrity, and Psilocybin for Chronic Pain
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Cannabis for Treatment-Resistant Depression, CBD Cardiovascular Benefits, Acidic Cannabinoids, Traumatic Brain Injury, and CBD-THC Interactions in Caffeinated Beverages
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: How Psychedelics Inspire Scientific Insight, CBD Research on Pain, Inflammation, Alzheimer’s, Cancer, and Heart Disease
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Cannabis Rescheduling Uncertainty, Psychedelic Polypharmacy, Psilocybin and Fear Extinction, Ontological Shock, and Cancer-Related Depression
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Trump Signs Order to Reclassify Cannabis as Schedule III, FDA/DEA Hemp Enforcement Challenges, Microdosing THC and CBD for Alzheimer’s, and More
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
Project CBD Newsletter: Trump Signs Executive Order to Reclassify Cannabis as Schedule III, Hemp Enforcement Challenges, Cannabinoids and Ovarian Cancer, Sleep Research, and More
The Project CBD newsletter covers the latest research into plant medicine, including cannabinoids and psychedelics, as well as noteworthy reading from around the web.
